Notice of Changes in Officers
Filed with TSE · · 2 pages · English
Towa Pharmaceutical Co., Ltd. on 6ix
Earlier from Towa Pharmaceutical
- FY2025 Briefing Script and Q&A Summary of financial results meeting(581K／27P)
- FY2025 Supplementary Material of Financial Results(1.0M／46P)
- FY2025 Consolidated Financial Results for the Year Ended March 31, 2026(Based on Japanese GAAP) (224K／22P)
- FY2025(3rd quarter) Briefing Script and Q&A Summary of financial results meeting(296K／17P)
- FY2025(3rd quarter) Supplementary Material of Financial Results(701K／24P)
Later from Towa Pharmaceutical
- Notice of Acquisition of Shares of Tanabe Pharma Factory Co., Ltd. and Transfer of Manufacturing and Marketing Approvals
- Notice of Completion of Payment for Disposal of Treasury Shares as Restricted Stock Compensation
- Notice of Completion of Payment for the Issuance of 1st Series Class A Preferred Shares through Third-Party Allotment
- Consolidated Financial Results for the Three Months Ended June 30, 2026 (Based on Japanese GAAP)
- FY2026(1st quarter) Briefing Script and Q&A Summary of financial results meeting(319K／15P)
Follow Towa Pharmaceutical into a list and get an email when it puts out news.
Follow Towa Pharmaceutical